Conference committee debates 340B transparency reporting in Senate Bill 2370
Lawmakers at a conference committee hearing discussed proposed reporting requirements tied to the federal 340B drug discount program in Senate Bill 2370, focusing on germaneness, data use, confidentiality and enforcement; no final action was taken and members asked for more study and another meeting.
The full story
A conference committee considering Senate Bill 2370 met to review proposed state reporting requirements related to the federal 340B drug discount program and its transparency, and members raised questions about whether the bill is germane to the vehicle, whether the state will gain useful information, and how confidentiality and civil penalties would be handled.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in